The MMA of 2003 under title 42 CFR
Part 423, Subpart D, established the requirements that Part D
sponsors must meet with regard to medication therapy management
(MTM) programs. Beginning in 2010, sponsors must offer an
interactive, person-to-person comprehensive medication review (CMR)
by a pharmacist or other qualified provider at least annually. A
CMR is a review of a beneficiary's medications, including
prescription and over-the-counter (OTC) medications, herbal
therapies, and dietary supplements, which is intended to aid in
assessing medication therapy and optimizing patient outcomes.
Sponsors must summarize the CMR and provide an individualized
written or printed summary to the beneficiary. The burden
associated with the time and effort necessary for Part D sponsors
to conduct CMRs with written summaries was estimated previously
(RIN 0938-AP77, OCN: 0938-0964).The ACA under Section 10328
specifies that the Secretary, in consultation with relevant
stakeholders, develop a standardized format for the action plan and
written or printed summary that are given to beneficiaries as a
result of their CMRs. The standardized format will replace whatever
formats Part D sponsors are using for their written CMR summaries
and action plans prior to 2013. Beginning in January, 2013, Part D
sponsors will collect information required by the new standardized
format, and provide that information to Medicare beneficiaries
after their CMRs on forms that comply with the requirements
specified by CMS for the standardized format (RIN 0938-AQ00). The
use of the standardized format will support a uniform and
consistent level of MTMP communications with beneficiaries, improve
the ability of beneficiaries to understand and manage their
medications safely and effectively, and support improved healthcare
outcomes and lower overall healthcare costs. The final standardized
format will be posted in the 2013 Call Letter for implementation by
Part D sponsors in January 2013.
PL:
Pub.L. 111 - 148 10328 Name of Law: Improvement In Part D
Medication Therapy Management (MTM) Programs
PL: Pub.L. 111 - 148 10328 Name of Law:
Improvement In Part D Medication Therapy Management (MTM)
Programs
The previous submission
included burden for programing systems and for training MTM
providers. In this current package we are removing that burden
since the systems programming and staff training that were needed
for the initial, startup implementation of the new standardized
format for 2013, is no longer required and because this package's
proposed revisions are nonmaterial. We have also adjusted burden
estimates that are based on an estimate of the increased number of
Part D enrollees through 2014 and 5 additional minutes for delivery
of the CMR with summary in standardized format; and average
eligibility rate for participation in Part D MTM programs, opt-out
rate of eligible beneficiaries, and delivery rate of CMRs with
summaries in standardized format. The net result is a lower
estimate of the annual number of CMRs delivered (280,352) compared
to the previous estimate (1,875,000). The nonmaterial revisions to
the standardized format will neither add nor detract from the
information collection burden.
$0
No
No
Yes
No
No
Uncollected
Gary Wirth 410 786-3977
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.